| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/978-1-4939-7046-9_17 |
| P698 | PubMed publication ID | 28540689 |
| P50 | author | Bin Wu | Q57161654 |
| P2093 | author name string | Daniel Miller | |
| P2860 | cites work | Kinetics of Rab27a-dependent actions on vesicle docking and priming in pancreatic beta-cells | Q46359364 |
| Expression of islet-specific microRNAs during human pancreatic development. | Q51947144 | ||
| MicroRNA profiling of developing and regenerating pancreas reveal post-transcriptional regulation of neurogenin3. | Q51975119 | ||
| Circulating microRNAs in patients with coronary artery disease. | Q54421687 | ||
| MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus | Q21090997 | ||
| The promoter of the pri-miR-375 gene directs expression selectively to the endocrine pancreas | Q21143807 | ||
| Targeted inhibition of miRNA maturation with morpholinos reveals a role for miR-375 in pancreatic islet development | Q21145874 | ||
| Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions | Q24319987 | ||
| Drosophila lacking microRNA miR-278 are defective in energy homeostasis | Q24539029 | ||
| Control of glucose homeostasis and insulin sensitivity by the Let-7 family of microRNAs | Q24617134 | ||
| miR-375 targets 3'-phosphoinositide-dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic beta-cells | Q24645027 | ||
| The microRNA signature in response to insulin reveals its implication in the transcriptional action of insulin in human skeletal muscle and the role of a sterol regulatory element-binding protein-1c/myocyte enhancer factor 2C pathway | Q24648295 | ||
| miR-375 maintains normal pancreatic alpha- and beta-cell mass | Q24657284 | ||
| Sequence-specific inhibition of small RNA function | Q24797869 | ||
| Circulating microRNA as a diagnostic marker in populations with type 2 diabetes mellitus and diabetic complications | Q26860056 | ||
| Silencing of microRNAs in vivo with 'antagomirs' | Q27860891 | ||
| High glucose down-regulates miR-29a to increase collagen IV production in HK-2 cells | Q28119012 | ||
| Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases | Q28131780 | ||
| MicroRNA-9 controls the expression of Granuphilin/Slp4 and the secretory response of insulin-producing cells | Q28251177 | ||
| MicroRNA miR-133 represses HERG K+ channel expression contributing to QT prolongation in diabetic hearts | Q28291882 | ||
| A pancreatic islet-specific microRNA regulates insulin secretion | Q28292726 | ||
| Glucose induces apoptosis of cardiomyocytes via microRNA-1 and IGF-1 | Q28294343 | ||
| MicroRNA expression is required for pancreatic islet cell genesis in the mouse | Q28585393 | ||
| Global estimates of the prevalence of diabetes for 2010 and 2030 | Q29547218 | ||
| Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001 | Q29614193 | ||
| Mechanisms linking obesity to insulin resistance and type 2 diabetes | Q29614887 | ||
| Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection | Q29615959 | ||
| MicroRNA-133 controls cardiac hypertrophy | Q29616572 | ||
| The Drosophila MicroRNA Mir-14 Suppresses Cell Death and Is Required for Normal Fat Metabolism | Q29618302 | ||
| A combined computational-experimental approach predicts human microRNA targets | Q29619021 | ||
| MicroRNA-143 regulates adipocyte differentiation | Q29619164 | ||
| Mechanisms for insulin resistance: common threads and missing links | Q29620447 | ||
| MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism | Q29871002 | ||
| MicroRNA and 3T3-L1 pre-adipocyte differentiation | Q30820724 | ||
| Genetic and clinical advances in congenital long QT syndrome | Q33164799 | ||
| MiRNA expression profile of human subcutaneous adipose and during adipocyte differentiation | Q33528956 | ||
| Loss of MicroRNA-192 promotes fibrogenesis in diabetic nephropathy | Q33702426 | ||
| Involvement of microRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic beta-cells. | Q33750755 | ||
| Integration of microRNA changes in vivo identifies novel molecular features of muscle insulin resistance in type 2 diabetes | Q33762245 | ||
| miR-192 mediates TGF-beta/Smad3-driven renal fibrosis | Q34124178 | ||
| Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes | Q34127486 | ||
| MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in vivo | Q34182469 | ||
| Expression of miR-33 from an SREBP2 intron inhibits cholesterol export and fatty acid oxidation | Q34231924 | ||
| MicroRNAs: emerging roles in lipid and lipoprotein metabolism | Q34266926 | ||
| Reciprocal actions of REST and a microRNA promote neuronal identity | Q34479303 | ||
| MicroRNAs and endocrine biology | Q34486152 | ||
| MicroRNA-133 regulates the expression of GLUT4 by targeting KLF15 and is involved in metabolic control in cardiac myocytes | Q35000436 | ||
| Serum circulating microRNA profiling for identification of potential type 2 diabetes and obesity biomarkers | Q35035110 | ||
| MicroRNAs involved in the mitogen-activated protein kinase cascades pathway during glucose-induced cardiomyocyte hypertrophy | Q35167928 | ||
| MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. | Q35652362 | ||
| miR-33a modulates ABCA1 expression, cholesterol accumulation, and insulin secretion in pancreatic islets. | Q35766891 | ||
| Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy | Q35804221 | ||
| Pathogenetic mechanisms of diabetic nephropathy | Q36153062 | ||
| Increased serum microRNAs are closely associated with the presence of microvascular complications in type 2 diabetes mellitus | Q36527551 | ||
| Advances in congenital long QT syndrome | Q36592074 | ||
| The metabolic syndrome: role of skeletal muscle metabolism | Q36606632 | ||
| Alterations in microRNA expression contribute to fatty acid-induced pancreatic beta-cell dysfunction | Q36906371 | ||
| Specific microRNAs modulate embryonic stem cell-derived neurogenesis. | Q37020782 | ||
| MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy | Q37039063 | ||
| SREBPs: the crossroads of physiological and pathological lipid homeostasis | Q37091373 | ||
| Role of microRNAs in diabetes | Q37097895 | ||
| MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity | Q37163542 | ||
| Role and therapeutic potential of microRNAs in diabetes | Q37611942 | ||
| Diabetes mellitus, a microRNA-related disease? | Q37855088 | ||
| MicroRNA-15a positively regulates insulin synthesis by inhibiting uncoupling protein-2 expression | Q39621720 | ||
| MiR-33 contributes to the regulation of cholesterol homeostasis. | Q39704194 | ||
| Regulation of the expression of components of the exocytotic machinery of insulin-secreting cells by microRNAs | Q40028213 | ||
| MicroRNA-124a regulates Foxa2 expression and intracellular signaling in pancreatic beta-cell lines | Q40140488 | ||
| Maturation of the regulation of GLUT4 activity by p38 MAPK during L6 cell myogenesis | Q40663944 | ||
| Upregulation of microRNA-1 and microRNA-133 contributes to arsenic-induced cardiac electrical remodeling | Q42716539 | ||
| Sirt1 and mir-9 expression is regulated during glucose-stimulated insulin secretion in pancreatic β-islets | Q42815144 | ||
| Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes | Q42826278 | ||
| Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study | Q44017895 | ||
| A comparison of the pathological spectrum of hypertensive, diabetic, and hypertensive-diabetic heart disease | Q44234271 | ||
| Diabetic nephropathy: Linking histology, cell biology, and genetics | Q46130537 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microRNA | Q310899 |
| P304 | page(s) | 225-239 | |
| P577 | publication date | 2017-01-01 | |
| P1433 | published in | Methods in Molecular Biology | Q15752859 |
| P1476 | title | Involvement of MicroRNAs in Diabetes and Its Complications | |
| P478 | volume | 1617 |
| Q55397060 | Crosstalk Between the Unfolded Protein Response, MicroRNAs, and Insulin Signaling Pathways: In Search of Biomarkers for the Diagnosis and Treatment of Type 2 Diabetes. |
| Q48175302 | Effect of chronic consumption of pistachios (Pistacia vera L.) on glucose metabolism in pre-diabetics and type 2 diabetics: A systematic review |
| Q60921699 | Exosomes of pasteurized milk: potential pathogens of Western diseases |
Search more.